Ads
related to: mrna stock price today
Search results
Moderna Investors Just Got Some Bullish News
Motley Fool via Yahoo Finance· 4 days agoShares of the biotech company have dropped 70% from their high back in 2021. Moderna might be about to enter a new...the pandemic. We got a taste of this...
5 Stocks Propelling S&P 500 to 25th Record High
Zacks via Yahoo Finance· 17 hours agoThe S&P 500 touches a record high for the 25th time this year, powered by technology stocks. We have highlighted five technology stocks, HPE, MRNA, AVGO,...
Novavax's stock surges almost 300% in the past month
AOL· 14 hours agoNovavax stock (NVAX) is on a tear — soaring nearly 300% in the past month to $19.56 per share — following several pieces of good news. The Food and Drug Administration (FDA ...
Is a Giant Short Squeeze Brewing in Novavax (NVAX) Stock?
InvestorPlace· 18 hours agoVaccine maker Novavax (NASDAQ:NVAX) saw its shares jump 18% on June 5 and another 20% in pre-market...
Why Is Novavax (NVAX) Stock Up 20% Today?
InvestorPlace· 1 day agoNovavax (NASDAQ:NVAX) is on a recovery trek after collapsing in late 2021. Regarding timeline, the latter two firms said that they would be able to...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 4 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Small Business - The Brewton Standard | The Brewton Standard
The Brewton Standard· 20 hours agoGAITHERSBURG, Md., June 06, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell ...
10 Health Care Stocks Whale Activity In Today's Session - AbbVie (NYSE:ABBV), Bristol-Myers Squibb...
Benzinga· 7 days agoThis event was a transfer of 50 contract(s) at a $45.00 strike. The total cost received by the writing party (or parties) was $37.5K , with a price of $750.0 per contract.
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 1 day agoNEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) (NASDAQ: MRNA). Such ...
Ginkgo Bioworks Stock: Bull vs. Bear
Motley Fool via Yahoo Finance· 7 days agoToday, investors with some tolerance for risk may consider taking a small position in Ginkgo...jumps out to me about Ginkgo -- and it's not good. More...
